| A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID‐19) pandemic: an international collaborative group HO Al‐Shamsi, W Alhazzani, A Alhuraiji, EA Coomes, RF Chemaly, ... The oncologist 25 (6), e936-e945, 2020 | 817 | 2020 |
| Prognostic significance of additional chromosomal abnormalities at the time of diagnosis in patients with chronic myeloid leukemia treated with frontline tyrosine kinase inhibitors A Alhuraiji, H Kantarjian, P Boddu, F Ravandi, G Borthakur, C DiNardo, ... American journal of hematology 93 (1), 84-90, 2018 | 56 | 2018 |
| Significance of thrombocytopenia in patients with primary and postessential thrombocythemia/polycythemia vera myelofibrosis L Masarova, A Alhuraiji, P Bose, N Daver, N Pemmaraju, J Cortes, ... European journal of haematology 100 (3), 257-263, 2018 | 55 | 2018 |
| Cancer in the Arab world HO Al-Shamsi, IH Abu-Gheida, F Iqbal, A Al-Awadhi Springer Nature, 2022 | 31 | 2022 |
| Viral hepatitis B and C in HIV-infected patients in Saudi Arabia A Alhuraiji, A Alaraj, S Alghamdi, A Alrbiaan, AA Alrajhi Annals of Saudi medicine 34 (3), 207-210, 2014 | 28 | 2014 |
| Life after ponatinib failure: outcomes of chronic and accelerated phase CML patients who discontinued ponatinib in the salvage setting P Boddu, AR Shah, G Borthakur, S Verstovsek, G Garcia-Manero, ... Leukemia & lymphoma 59 (6), 1312-1322, 2018 | 23 | 2018 |
| Clinical course and outcomes of COVID‐19 in hematopoietic cell transplant patients, a regional report from the Middle East R El Fakih, A Haroon, F Alfraih, MK Al-Khabori, M Alzahrani, A Alhuraiji, ... Bone Marrow Transplantation 56 (9), 2144-2151, 2021 | 21 | 2021 |
| Distinguishing thymoma from T-lymphoblastic leukaemia/lymphoma: a case-based evaluation P Boddu, B Thakral, A Alhuraiji, N Pemmaraju, T Kadia, M Ohanian, ... Journal of Clinical Pathology 72 (3), 251-257, 2019 | 19 | 2019 |
| New-onset diabetes after kidney transplantation: Incidence, risk factors, and outcomes H Aleid, A Alhuraiji, A Alqaraawi, A Abdulbaki, M Altalhi, M Shoukri, ... Saudi Journal of Kidney Diseases and Transplantation 27 (6), 1155-1161, 2016 | 17 | 2016 |
| Acute lymphoblastic leukemia secondary to myeloproliferative neoplasms or after lenalidomide exposure A Alhuraiji, K Naqvi, YO Huh, C Ho, S Verstovsek, P Bose Clinical Case Reports 6 (1), 155, 2018 | 16 | 2018 |
| Clinical features and outcome of patients with poor-prognosis myelofibrosis based on platelet count <50 x 109/L: A single-center experience in 1100 myelofibrosis … A Alhuraiji, L Masarova, P Bose, NG Daver, JE Cortes, S Pierce, ... Journal of Clinical Oncology 34 (15_suppl), 7068-7068, 2016 | 15 | 2016 |
| Optimal Management of Acute Lymphoblastic Leukemia (ALL) in Adult Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic. A Alhuraiji, S Eldadah, F Alfraih, R Pandita, A Absi, A Hanbali, M Aljurf, ... The Gulf Journal of Oncology 1 (33), 7-18, 2020 | 10 | 2020 |
| Elevated alanine aminotransferase levels in HIV-infected persons without hepatitis B or C virus coinfection S Alghamdi, A Alrbiaan, A Alaraj, A Alhuraiji, M Alghamdi, A Alrajhi Annals of Saudi medicine 36 (4), 288-291, 2016 | 10 | 2016 |
| A Practical Approach to the Management of Cancer Patients During the Novel Coronavirus Disease 2019 (COVID-19) Pandemic: An International Collaborative Group. Oncologist … HO Al-Shamsi, W Alhazzani, A Alhuraiji, EA Coomes, RF Chemaly, ... DOI: https://doi. org/10.1634/theoncologist 213, 2020 | 9 | 2020 |
| 1: CAS: 528: DC% 2BB3cXhvFCrtrjM: A practical approach to the management of cancer patients during the novel coronavirus disease 2019 (COVID-19) pandemic: an international … HO Al-Shamsi, W Alhazzani, A Alhuraiji, EA Coomes, RF Chemaly, ... Oncologist, 2020 | 9 | 2020 |
| Evolution of Cancer Care in Response to the COVID‐19 Pandemic EA Coomes, HO Al‐Shamsi, BM Meyers, W Alhazzani, A Alhuraiji, ... The Oncologist 25 (9), e1426-e1427, 2020 | 8 | 2020 |
| Hematopoietic Stem Cell Transplant in Adolescent and Young Adults With Fanconi Anemia Is Feasible With Acceptable Toxicity, With Those Surviving 100 Days Posttransplant Having … A Alhuraiji, H Alzahrani, F Al Mohareb, N Chaudhri, F Alsharif, ... Experimental and Clinical Transplantation: Official Journal of the Middle …, 2016 | 7 | 2016 |
| General oncology care in Kuwait A Alhuraiji, J Abdullah, BO Almutairi, J Albarrak Cancer in the Arab World, 99-114, 2022 | 5 | 2022 |
| Donor-derived extramedullary acute promyelocytic leukemia post kidney transplant A Alhuraiji, W Chebbo, G El-Gohary, N Chaudhri, F Almohareb, K Ibrahim, ... Annals of hematology 94, 505-507, 2015 | 5 | 2015 |
| Management of humoral secondary immunodeficiency in hematological malignancies and following hematopoietic stem cell transplantation: Regional perspectives MC Ar, R El Fakih, S Gabbassova, A Alhuraiji, F Nasr, A Alsaeed, ... Leukemia Research, 107365, 2023 | 4 | 2023 |
Prof. Humaid Obaid Al-ShamsiProfessor - College of Medicine - Ras Al Khaimah Medical and Health Sciences University在 medportal.ca 的电子邮件经过验证
